Fulcrum Therapeutics (FULC) Stock Price, Quote, News & History | Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD83,621.29+0.84%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Fulcrum Therapeutics Inc (FULC) Stock Price, Quote, News & History

FULCNASDAQ

Trade with Public

Trade with Public

$3.77

0.020.53%

Last update: Oct 9, 4:00 PM

$3.78

0.03010.8%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$3.75

Close

$3.77

Volume / Avg.

1.80M / 1.57M

Day Range

$3.77 - $3.77

52 Wk Range

2.83 - 15.74

Market Cap

$286.11M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

52

Short Interest

9.41%

Days to Cover

4.48

Recent Fulcrum Therapeutics, Inc. News

Fulcrum Therapeutics Strikes All-Stock Merger With Slate Medicines

Fulcrum Therapeutics and Slate Medicines merge in an all-stock deal to develop migraine drugs, backed by a $245M private placement.

Vandana Singh

What's Going On With Fulcrum Therapeutics Stock On Thursday?

Fulcrum Therapeutics halts pociredir development after FDA concerns over malignancy risk and begins a strategic review.

Vandana Singh

This Truist Securities Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

Analyst rating changes: Stifel and Piper Sandler downgrade FULC, while Truist, Jefferies downgrade TMHC and SARO respectively. See more views.

Avi Kapoor

CrowdStrike To Gain 7%? Here Are 10 Top Analyst Forecasts For Tuesday

Wall Street analysts change ratings for top stocks: CRWD price target raised, FULC target lowered, HPQ target raised, PRAX target cut, GNSS target raised, INTU target lowered, GH target raised, CRDO target raised, PRAX target lowered, NU target cut.

Avi Kapoor

This Goldman Sachs Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday

Wall Street analysts changed outlook on top names. Read about analyst rating downgrades on ED, FULC, INTU, NU.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-65.78M

Investing Cash Flow (TTM)

-96.87M

Financing Cash Flow (TTM)

168.41M

Free Cash Flow (TTM)

-66.14M

Capital Expenditure (TTM)

-365.00K

Net Change in Cash (TTM)

5.77M

Analyst Trends and Forecast

2

2

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.5

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$25.98M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.92

Earnings Yield % (TTM)

-32.22%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.07

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$48.47M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-